Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms

Inclusion Criteria: * Symptoms of OAB (urgency, with or without urge incontinence, usually with frequency and nocturia) for ≥3 or more months. * Patients may be included if they are on another OAB medication; however, patients must washout from other OAB medications for at least 7 days prior to receiving solifenacin succinate. Previous non-drug treatment of OAB is allowed if it has been established at least 4 weeks prior to study entry and is continued throughout the study. Exclusion Criteria: * -Significant stress incontinence or mixed stress/urge incontinence where stress is the predominant factor * Evidence of urinary tract infection; chronic inflammation such as interstitial cystitis and bladder stones * Clinically significant outflow obstruction (benign prostatic hyperplasia)